Metabion has increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives to support growing demand. The company built and established a state- of-the-art oligonucleotide manufacturing facility dedicated to small-, mid- and large-scale oligonucleotide components for in vitro diagnostics (IVD)/analyte-specific reagents (ASRs) oligonucleotides, as well as mid-/large-scale oligos for R&D and therapeutic applications.                  ...